Wiley Rein Bolsters Its Intellectual Property Practice with the Addition of Biotech Patent Group

February 2014

Wiley Rein is pleased to announce that A. Neal Seth, Lawrence M. Sung, and Mary Sylvia have joined the firm as partners in its esteemed Intellectual Property Practice.  The team—which brings a dynamic combination of scientific credentials and legal acumen—will advise clients on patent litigation strategy and appeals, patent prosecution and portfolio matters, dispute settlements, and technology transfer in the biotechnology, pharmaceutical, medical devices, and chemical industries.

The group, which comes to Wiley Rein from BakerHostetler, has a diverse background serving major companies, as well as start-ups.  All three partners are registered patent attorneys.  Mr. Seth focuses on patent litigation and appeals.  Mr. Sung has 20 years of experience in patent counseling, litigation, and technology transfer.  Ms. Sylvia has nearly 30 years of experience in microbiology and patent law and was trained as a molecular biologist.

“We are pleased to welcome these talented lawyers to our firm,” said Chairman Richard E. Wiley.  “Their outstanding accomplishments and deep patent experience in the fast-growing life sciences and biotech sectors will greatly benefit our clients.”

For more information, please contact A. Neal Seth at 202.719.4179 or, Lawrence M. Sung at 202.719.4181 or, and Mary Sylvia at 202.719.4178 or

Read Time: 1 min
Jump to top of page

By using this site, you agree to our updated Privacy PolicyTerms & Conditions, and Cookies Policy.